Article
Novel treatment targets in sarcoma: more than just the GIST.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2014
Shoushtari Alexander N, Van Tine Brian A, Schwartz Gary K
Abstract excerpt
Sarcomas are rare tumors comprising a heterogeneous group of more than 50 histologic subtypes, the majority of which do not respond well to cytotoxic chemotherapy. This has fueled research into the distinct molecular mechanisms of tumorigenesis and disease progression for various sarcoma subtypes. Gastrointestinal stromal tumors and liposarcomas are presented as paradigms of molecular classification that have led...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
